Meeting Report

Melanoma: ASCO20 Virtual Scientific Program Highlights for the Advanced Practitioner

Lisa Kottschade, APRN, MSN, CNP

Mayo Clinic


J Adv Pract Oncol 2020;11(6):609-611 | https://doi.org/10.6004/jadpro.2020.11.6.8 | Ā© 2020 Harborsideā„¢


  

ABSTRACT

With coverage by The ASCO Post, Lisa Kottschade, APRN, MSN, CNP, of Mayo Clinic, reviews clinical data on which patients with metastatic melanoma should receive combination therapy vs. single-agent PD-1 up front, and what to do at the time of progression on PD-1 monotherapy.




For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2020 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.